Leading science, pioneering therapies

CRM Publications

Found 8 results
Filters: Keyword is Sequence Deletion  [Clear All Filters]
Spensberger D, Kotsopoulou E, Ferreira R, Broccardo C, Scott LM, Fourouclas N, Ottersbach K, Green AR, Göttgens B.  2012.  Deletion of the Scl +19 enhancer increases the blood stem cell compartment without affecting the formation of mature blood lineages.Exp Hematol. 40(7):588-598.e1.
Wallace HAC, Marques-Kranc F, Richardson M, Luna-Crespo F, Sharpe JA, Hughes J, Wood WG, Higgs DR, Smith AG.  2007.  Manipulating the mouse genome to engineer precise functional syntenic replacements with human sequence.Cell. 128(1):197-209.
Niwa H, Masui S, Chambers I, Smith AG, Miyazaki J-ichi.  2002.  Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells.Mol Cell Biol. 22(5):1526-36.
Sprengel R, Suchanek B, Amico C, Brusa R, Burnashev N, Rozov A, Hvalby O, Jensen V, Paulsen O, Andersen P et al..  1998.  Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo.Cell. 92(2):279-89.
Henderson CJ, Smith AG, Ure J, Brown K, Bacon EJ, Wolf CR.  1998.  Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases.Proc Natl Acad Sci U S A. 95(9):5275-80.
Johnson D, Harrison S, Pineda N, Heinlein C, al-Shawi R, Bishop JO.  1995.  Localization of the response elements of a gene induced by intermittent growth hormone stimulation.J Mol Endocrinol. 14(1):35-49.
Macleod D, Charlton J, Mullins JJ, Bird AP.  1994.  Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island.Genes Dev. 8(19):2282-92.